Sort
172,184 grants matching “inflammation”
Cell Migration in 3D microenvironments
$2,956,754Clare Michal Waterman · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Paramyxoviruses as Vaccine Vectors Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
$2,955,452Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
UAB-MISS MACS/WIHS Combined Cohort Study
$2,954,063Mirjam-Colette Kempf · University Of Alabama At Birmingham · U01 · FY2022 · HL
Delirium, Dementia, and the Vulnerable Brain: An Integrative Approach
$2,952,931Sharon K Inouye · Hebrew Rehabilitation Center For Aged · P01 · FY2019 · AG
Ca2+ signaling and HCO3- secretion by exocrine glands
$2,952,041Shmuel Muallem · National Institute Of Dental & Craniofacial Research · ZIA · FY2020 · DE
Delirium, Dementia, and the Vulnerable Brain: An Integrative Approach
$2,945,906Sharon K Inouye · Hebrew Rehabilitation Center For Aged · P01 · FY2020 · AG
Manipulating natural host immunoregulation via IDO during viral Infection
$2,944,781Andrew Lee Mellor · Augusta University · U01 · FY2010 · AI
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$2,943,796Alan Sher · Niaid Extramural Activities · Z01 · FY2007 · AI
Pathogenesis and Novel Therapeutic Targets of Steatotic Liver Disease and Cancer
$2,942,382Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA
SCCOR in Host Factors in Chronic Lung Disease
$2,942,099Richard C Boucher · Univ Of North Carolina Chapel Hill · P50 · FY2006 · HL
Carbon Monoxide: Novel Opportunities for Therapy
$2,941,791Augustine M Choi · Brigham And Women'S Hospital · P01 · FY2011 · HL
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$2,941,694Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Microbiota and Allergic Asthma Precision Prevention (MAAP2)
$2,940,814Christine C Johnson · Henry Ford Health System · P01 · FY2020 · AI
Growth factors, neuroinflammation, exercise, and brain integrity
$2,938,975Paul M Thompson · University Of Southern California · RF1 · FY2014 · AG
Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease
$2,937,723Melissa Erin Murray · Mayo Clinic Jacksonville · R01 · FY2025 · AG
Pharmacogenomics and Risk of Cardiovascular Disease
$2,935,651Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · U01 · FY2007 · HL
Genome-Wide Association of Platelet Phenotypes
$2,933,296Lewis C Becker · Johns Hopkins University · R01 · FY2007 · HL
Oligodendrocyte Progenitors and Hyaluronan-mediated Mechanisms of Human Vascular White Matter Injury
$2,931,990Stephen Arthur Back · Oregon Health & Science University · RF1 · FY2020 · AG
A Genome-wide Association Study of Childhood Respiratory Outcomes
$2,931,009William James Gauderman · University Of Southern California · R01 · FY2007 · HL
Laboratory of Molecular Imaging and Nanomedicine
$2,930,853Xiaoyuan Chen · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2012 · EB
The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU)
$2,928,493Charles W. Flexner · Johns Hopkins University · UM1 · FY2014 · AI
Immunobiology for Marrow Allografts for Leukemia
$2,928,248Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2017 · CA
Immunobiology for Marrow Allografts for Leukemia
$2,928,248Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
Immunobiology for Marrow Allografts for Leukemia
$2,928,248Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
Development of Complement Modulating Therapeutics for AMD
$2,927,483Gregory S Hageman · University Of Iowa · R24 · FY2007 · EY